How zinc intake affects growth and brain development in preterm infants
Official title: The Impact of Zinc Intake on Nutritional Status and Brain Development Among Preterm Infants
Funded at Brigham and Women's Hospital · NIH-10894782 · Data updated 2026-11-12
This study is looking at how zinc intake during a preterm baby's stay in the NICU can help them grow stronger and support their brain development, with the goal of finding the best amount of zinc to help these little ones thrive.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 7, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $165,960 |
| NIH project number | 5K23HD104000-03 |
| Project ID | NIH-10894782 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are preterm infants who are receiving care in a neonatal intensive care unit.
✕Less likely to help
Patients who are full-term infants or those who do not require NICU care may not benefit from this research.
What this research studies
This research investigates the role of zinc intake during the critical period of hospitalization in the neonatal intensive care unit (NICU) for preterm infants. It aims to understand how varying levels of zinc can influence the growth of lean mass, which is essential for healthy organ development, and how this, in turn, affects brain growth and long-term neurodevelopmental outcomes. By assessing the nutritional status of these infants, the study seeks to establish optimal zinc intake levels that could enhance their overall development. The research will involve monitoring zinc intake and its effects on growth metrics and brain development over time.
Why it matters
Potential benefit: If successful, this research could lead to improved nutritional guidelines for preterm infants, enhancing their growth and brain development.
How similar studies have gone: Previous research has indicated that optimizing nutrient intake in preterm infants can significantly improve growth and developmental outcomes, suggesting a promising avenue for this study.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Bell, Katherine — Brigham and Women's Hospital
- Study coordinator: Bell, Katherine
Related research
Other NIH-funded projects on the same topics.
-
Darbepoetin and iron together to cut transfusions and boost brain development in preterm babies
A study tests whether giving darbepoetin with slow-release iron to critically preterm infants reduces blood transfusions and supports healthier iron levels and brain development.
-
Investigating how racial discrimination and vitamin D levels affect preterm birth in Black women
This study is looking at how experiences of racial discrimination, feelings of depression, and low vitamin D levels might affect the risk of preterm birth in Black women, by examining blood samples to find out how these factors work together during pregnancy.
-
Understanding brain nutrition for very preterm infants
This work aims to find a better way to measure how well very preterm infants are nourished to support their brain development.
-
Darbepoetin and Iron for Preterm Infants to Reduce Transfusions and Support Brain Development
This research explores if a combination of darbepoetin and slow-release iron can reduce the need for blood transfusions and support healthy brain development in very premature babies.
-
Creating a nutritional indicator for brain health in very preterm infants
This study is looking at a new way to check how well very premature babies are getting the nutrition they need to grow healthy and support their brain development, using special tools in the NICU to help doctors provide the best care possible.
-
Using Darbepoetin and iron to reduce blood transfusions and improve brain development in preterm infants
This study is looking at how a medication called Darbepoetin, along with a special type of iron, can help preterm babies make more red blood cells and need fewer blood transfusions, which could help their brain development.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.